{"data":{"id":"us/21-cfr-347.3","jurisdiction":"us","citation":"21 CFR 347.3","heading":"Definitions.","body":"As used in this part:\nAstringent drug product. A drug product applied to the skin or mucous membranes for a local and limited protein coagulant effect.\nLip protectant drug product. A drug product that temporarily prevents dryness and helps relieve chapping of the exposed surfaces of the lips; traditionally called “lip balm.”\nPoison ivy, oak, sumac dermatitis. An allergic contact dermatitis due to exposure to plants of the genus Rhus (poison ivy, poison oak, poison sumac), which contain urushiol, a potent skin-sensitizer.\nSkin protectant drug product. A drug product that temporarily protects injured or exposed skin or mucous membrane surfaces from harmful or annoying stimuli, and may help provide relief to such surfaces.","path":["Title 21—Food and Drugs","CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES","SUBCHAPTER D—DRUGS FOR HUMAN USE","PART 347—SKIN PROTECTANT DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE","Subpart A—General Provisions"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-21.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:24:47Z","sha256":"49d5c45fc83ef675e10988f29eab5e23dc16d0809dadf8a76e4cc899bd22d438","source_id":"us-cfr","stale":true,"prev":"us/21-cfr-347.1","next":"us/21-cfr-347.10"},"notice":"GroundRules: Original legal text. Not legal advice."}